tiprankstipranks
Trending News
More News >
Bio-Techne (DE:TE1)
FRANKFURT:TE1
Germany Market

Bio-Techne (TE1) Ratios

Compare
0 Followers

Bio-Techne Ratios

DE:TE1's free cash flow for Q3 2025 was $0.68. For the 2025 fiscal year, DE:TE1's free cash flow was decreased by $ and operating cash flow was $0.00. See a summary of the company’s cash flow.
Ratios
TTM
Jun 24Jun 23Jun 22Jun 21
Liquidity Ratios
Current Ratio
4.84 4.84 3.44 3.35 4.88
Quick Ratio
3.50 3.50 2.64 2.59 3.92
Cash Ratio
1.41 1.41 0.98 1.31 1.37
Solvency Ratio
0.58 0.58 0.63 0.33 0.48
Operating Cash Flow Ratio
1.98 1.98 1.85 2.31 1.92
Short-Term Operating Cash Flow Coverage
22.72 22.72 13.32 14.61 9.31
Net Current Asset Value
$ -50.69M$ -50.69M$ 11.76M$ -181.12M$ -125.48M
Leverage Ratios
Debt-to-Assets Ratio
0.17 0.17 0.14 0.19 0.21
Debt-to-Equity Ratio
0.23 0.23 0.19 0.27 0.31
Debt-to-Capital Ratio
0.19 0.19 0.16 0.21 0.24
Long-Term Debt-to-Capital Ratio
0.15 0.15 0.13 0.17 0.20
Financial Leverage Ratio
1.34 1.34 1.35 1.44 1.47
Debt Service Coverage Ratio
18.17 18.17 10.68 6.57 7.92
Interest Coverage Ratio
26.66 26.66 26.23 10.72 3.89
Debt to Market Cap
0.03 0.03 0.02 0.02 0.04
Interest Debt Per Share
2.97 2.97 2.15 2.80 2.96
Net Debt to EBITDA
0.60 0.60 0.37 0.86 0.77
Profitability Margins
Gross Profit Margin
67.72%67.72%68.42%67.97%65.41%
EBIT Margin
30.78%30.78%28.28%17.41%40.03%
EBITDA Margin
40.52%40.52%38.00%27.76%50.62%
Operating Profit Margin
26.30%26.30%26.83%16.06%10.11%
Pretax Profit Margin
29.79%29.79%27.26%15.92%37.43%
Net Profit Margin
25.10%25.10%24.61%15.08%31.04%
Continuous Operations Profit Margin
25.11%25.11%23.80%14.99%31.04%
Net Income Per EBT
84.23%84.23%90.27%94.76%82.93%
EBT Per EBIT
113.29%113.29%101.62%99.08%370.21%
Return on Assets (ROA)
10.81%10.81%11.86%6.20%11.31%
Return on Equity (ROE)
14.51%14.51%15.99%8.94%16.60%
Return on Capital Employed (ROCE)
11.91%11.91%14.00%7.09%3.89%
Return on Invested Capital (ROIC)
9.95%9.95%12.01%6.56%3.17%
Return on Tangible Assets
23.17%23.17%28.91%17.47%29.29%
Earnings Yield
2.22%2.22%2.00%0.80%2.27%
Efficiency Ratios
Receivables Turnover
5.20 5.20 5.68 6.40 6.03
Payables Turnover
14.29 14.29 10.31 10.15 11.07
Inventory Turnover
2.14 2.14 2.47 2.55 2.48
Fixed Asset Turnover
3.50 3.50 3.83 3.30 2.98
Asset Turnover
0.43 0.43 0.48 0.41 0.36
Working Capital Turnover Ratio
2.46 2.46 2.81 2.41 2.04
Cash Conversion Cycle
215.36 215.36 176.37 163.94 174.92
Days of Sales Outstanding
70.15 70.15 64.23 57.00 60.55
Days of Inventory Outstanding
170.76 170.76 147.55 142.91 147.36
Days of Payables Outstanding
25.55 25.55 35.41 35.97 32.99
Operating Cycle
240.91 240.91 211.78 199.91 207.91
Cash Flow Ratios
Operating Cash Flow Per Share
1.62 1.62 2.07 2.27 1.34
Free Cash Flow Per Share
1.38 1.38 1.79 1.99 1.00
CapEx Per Share
0.24 0.24 0.29 0.29 0.34
Free Cash Flow to Operating Cash Flow
0.85 0.85 0.86 0.87 0.75
Dividend Paid and CapEx Coverage Ratio
2.87 2.87 3.42 3.75 2.04
Capital Expenditure Coverage Ratio
6.65 6.65 7.24 7.95 3.97
Operating Cash Flow Coverage Ratio
0.56 0.56 1.00 0.84 0.47
Operating Cash Flow to Sales Ratio
0.22 0.22 0.29 0.38 0.28
Free Cash Flow Yield
1.68%1.68%2.06%1.76%1.52%
Valuation Ratios
Price-to-Earnings (P/E) Ratio
44.98 44.98 49.97 124.26 44.00
Price-to-Sales (P/S) Ratio
11.29 11.29 12.30 18.74 13.66
Price-to-Book (P/B) Ratio
6.52 6.52 7.99 11.10 7.30
Price-to-Free Cash Flow (P/FCF) Ratio
59.36 59.36 48.49 56.67 65.73
Price-to-Operating Cash Flow Ratio
50.44 50.44 41.80 49.54 49.16
Price-to-Earnings Growth (PEG) Ratio
9.73 9.73 0.55 -3.16 0.33
Price-to-Fair Value
6.52 6.52 7.99 11.10 7.30
Enterprise Value Multiple
28.45 28.45 32.72 68.36 27.75
Enterprise Value
13.10B 13.10B 13.75B 17.67B 10.38B
EV to EBITDA
28.45 28.45 32.72 68.36 27.75
EV to Sales
11.53 11.53 12.44 18.98 14.05
EV to Free Cash Flow
60.63 60.63 49.04 57.39 67.60
EV to Operating Cash Flow
51.51 51.51 42.27 50.17 50.56
Tangible Book Value Per Share
3.56 3.56 2.21 0.72 0.89
Shareholders’ Equity Per Share
12.51 12.51 10.84 10.14 9.04
Tax and Other Ratios
Effective Tax Rate
0.16 0.16 0.13 0.06 0.17
Revenue Per Share
7.23 7.23 7.05 6.01 4.83
Net Income Per Share
1.81 1.81 1.73 0.91 1.50
Tax Burden
0.84 0.84 0.90 0.95 0.83
Interest Burden
0.97 0.97 0.96 0.91 0.94
Research & Development to Revenue
0.08 0.08 0.08 0.08 0.09
SG&A to Revenue
0.31 0.31 0.31 0.31 0.33
Stock-Based Compensation to Revenue
0.03 0.03 0.04 0.05 0.04
Income Quality
0.89 0.89 1.24 2.52 0.89
Currency in USD
What am I Missing?
Make informed decisions based on Top Analysts' activity
Know what industry insiders are buying
Get actionable alerts from top Wall Street Analysts
Find out before anyone else which stock is going to shoot up
Get powerful stock screeners & detailed portfolio analysis